Researchers at King Abdullah University of Science and Technology (KAUST) have developed a wearable microneedle patch capable of continuously measuring drug levels beneath the skin. The device wirelessly transmits real-time data to a smartphone, using tiny microneedles to access interstitial fluid and electrochemical biosensors. The technology was successfully demonstrated by tracking vancomycin concentrations in preclinical studies. Why it matters: This innovation could enable more precise and personalized medicine dosing by providing continuous insight into drug pharmacokinetics, improving safety and efficacy compared to current periodic blood tests.
KAUST, Tufts, and JIHS researchers created pangenome graphs using Saudi and Japanese samples, named JaSaPaGe. These graphs address the underrepresentation of these populations in existing pangenome databases, which are used as references for understanding individual DNA. The population-specific pangenomes are expected to improve variant calling and diagnostic accuracy for genetic disorders in these groups. Why it matters: This work promotes precision medicine and reduces diagnostic gaps for underrepresented populations by providing more relevant genetic baselines.
MBZUAI and Quris-AI have partnered to launch a Bio-AI center in Abu Dhabi during Abu Dhabi Sustainability Week. The center will focus on developing personalized medications tailored to the MENA region's diverse populations, leveraging Quris-AI's 'patient-on-a-chip' technology and MBZUAI's AI expertise. Quris-AI is establishing a UAE subsidiary, Quris-UAE, in Abu Dhabi as part of this collaboration. Why it matters: This initiative positions Abu Dhabi as a hub for Bio-AI research and personalized medicine, potentially accelerating drug development and reducing clinical trial failures in the region.
MBZUAI researchers developed FetalCLIP, an AI model trained on 210,000 ultrasound images for fast and reliable interpretation of fetal scans. MBZUAI's President Eric Xing contributed to the General Expression Transformer (GET), an AI foundation model acting as a biological simulator to predict gene behavior. MBZUAI and Carleton University created MedPromptX for quicker disease diagnosis and treatment plans using multimodal AI. Why it matters: These AI advancements from MBZUAI have the potential to revolutionize healthcare in the region and globally, from prenatal care to drug discovery and personalized medicine.
The UAE is actively integrating artificial intelligence into six key sectors to enhance public services and improve citizens' quality of life. These applications include leveraging AI for advanced diagnostics and personalized medicine in healthcare, alongside smart city initiatives for efficient urban management. The government also employs AI-powered chatbots and predictive analytics to streamline citizen interactions and policy development, while also utilizing AI in education for personalized learning and in environmental monitoring for sustainability. Why it matters: This comprehensive integration demonstrates the UAE's strategic vision for AI adoption, positioning the nation as a regional leader in utilizing advanced technology for national development and public benefit.
Saudi Arabia is undergoing a rapid digital transformation in its healthcare sector, driven by Vision 2030. AI is being deployed for early disease detection, personalized medicine, and remote patient monitoring. These changes aim to improve healthcare accessibility and efficiency across the Kingdom. Why it matters: This digital shift promises to enhance patient outcomes and establish Saudi Arabia as a leader in tech-driven healthcare innovation within the region.
KAUST is collaborating with medical centers and Alfaisal University to integrate smart and digital tools into the Saudi healthcare system. A key objective is to improve understanding of disease mechanisms for better diagnosis, treatment, and prevention, aligning with KSA's Vision 2030. KAUST has partnered with Alfaisal University to establish the Kingdom’s first M.D./Ph.D. program. Why it matters: These partnerships aim to transition Saudi Arabia's healthcare system towards precision and personalized medicine by training practitioners in AI and smart technologies.
KAUST's Sciencetown podcast episode 23 features researcher Dana Al-Sulaiman discussing portable biosensing technologies for cancer detection. These devices aim to enable liquid biopsies for early screening and personalized treatment. The biosensors gather clinical information from biological samples to inform clinical decisions. Why it matters: This research can advance non-invasive diagnostics and personalized medicine in the region.